Evidence map›Paper›PMID 38744987›Full record

ArticleNature chemical biology2024

The β-subunit of tryptophan synthase is a latent tyrosine synthase.

Patrick J Almhjell, Kadina E Johnston, Nicholas J Porter, Jennifer L Kennemur, Vignesh C Bhethanabotla, Julie Ducharme, Frances H Arnold

Abstract read
In one paragraph

Article in Nature chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Phage-assisted continuous evolution of enzymes for noncanonical tyrosine biosynthesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Promiscuity-Guided Enzyme Evolution via Substrate Multiplexed Screening.Angewandte Chemie (International ed. in English) · 2026
    Review
  4. Article
  5. ASH: A Multi-Scale, Multi-Theory Modeling Program.Journal of computational chemistry · 2026
    Article
  6. Article
  7. Article
  8. Optimizing L-Tryptophan Production inJournal of microbiology and biotechnology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrick J AlmhjellDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0003-0977-841X
Kadina E JohnstonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-2214-3534
Nicholas J PorterDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Jennifer L KennemurDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Vignesh C BhethanabotlaDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Julie DucharmeDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Frances H ArnoldDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA. frances@cheme.caltech.edu.ORCID http://orcid.org/0000-0002-4027-364X

Funding

Development of a Biocatalytic Platform for Convergent Synthesis of Chiral AminesR01GM125887 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2018 to 2021
$1.2M
Predoctoral Biotechnology Leadership Training in Micro/NanomedicineT32GM112592 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2015 to 2019
$1.1M
Development of Biocatalysts for Chemodivergent Functionalizations of HeterocyclesF32GM143797 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI KENNEMUR, JENNIFER L. · 2022 to 2024
$210k
Helen Hay Whitney Foundation (HHWF) MerckNational Science Foundation (NSF) DGE-1745301NIGMS NIH HHS F32 GM143797NIGMS NIH HHS R01 GM125887NIGMS NIH HHS T32 GM112592U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1F32GM143797-01A1U.S. Department of Health & Human Services | National Institutes of Health (NIH) 5T32GM112592-5U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM125887
6 · The paper itself

Abstract

Aromatic amino acids and their derivatives are diverse primary and secondary metabolites with critical roles in protein synthesis, cell structure and integrity, defense and signaling. All de novo aromatic amino acid production relies on a set of ancient and highly conserved chemistries. Here we introduce a new enzymatic transformation for L-tyrosine synthesis by demonstrating that the β-subunit of tryptophan synthase-which natively couples indole and L-serine to form L-tryptophan-can act as a latent 'tyrosine synthase'. A single substitution of a near-universally conserved catalytic residue unlocks activity toward simple phenol analogs and yields exclusive para carbon-carbon bond formation to furnish L-tyrosines. Structural and mechanistic studies show how a new active-site water molecule orients phenols for a nonnative mechanism of alkylation, with additional directed evolution resulting in a net >30,000-fold rate enhancement. This new biocatalyst can be used to efficiently prepare valuable L-tyrosine analogs at gram scales and provides the missing chemistry for a conceptually different pathway to L-tyrosine.

Indexed as

Tryptophan SynthaseTyrosineBiocatalysisCatalytic DomainModels, MolecularProtein SubunitsTryptophanTyrosine Phenol-LyaseProtein SubunitsTryptophanTryptophan SynthaseTyrosineTyrosine Phenol-Lyase

Identifiers

PMID38744987
PMCPMC11288773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.